Ligand Design for G Protein-Coupled Receptors

Ligand Design for G Protein-Coupled Receptors

  • Digital

Currently unavailable

We can notify you when this item is back in stock

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

G protein-coupled receptors (GPCRs) are one of the most important target classes in pharmacology and are the target of many blockbuster drugs. Yet only with the recent elucidation of the rhodopsin structure have these receptors become amenable to a rational drug design. Based on recent examples from academia and the pharmaceutical industry, this book demonstrates how to apply the whole range of bioinformatics, chemoinformatics and molecular modeling tools to the rational design of novel drugs targeting GPCRs. It is essential reading for medicinal chemists and drug designers working with this largest class of drug targets in the human genome.show more

Product details

  • Digital | 284 pages
  • Wiley-VCH Verlag GmbH
  • Weinheim, Germany
  • 3527608249
  • 9783527608249

Table of contents

Preface.1. G Protein-coupled Receptors in the Human Genome (R. Fredriksson & H. Schioth).2. Why G Protein-coupled Receptors Databases are Needed (J. Haiech, et al.).3. A Novel Drug Screening Assay for G Protein-coupled Receptors (B. O'Dowd, et al.).4. Importance of GPCR Dimerization for Function: The Case of the Class C GPCRs (L. Prezeau, et al.).5. Molecular Mechanisms of GPCR Activation (R. Bywater & P. Denny-Gouldson).6. Allosteric Properties and Regulation of G Protein-coupled Receptors (J. Galzi, et al.).7. Chemogenomics Approaches to Ligand Design (T. Klabunde).8. Strategies for the Design of pGPCR-targeted Libraries (N. Savchuk, et al.).9. Ligand-based Rational Design: Virtual Screening (D. Clark & C. Higgs).10. 3-D Structure of G Protein-coupled Receptors (L. Pardo, et al.).11. 7TM Models in Structure-based Drug Design (F. Blaney, et al.).12. Receptor-based Rational Design: Virtual Screening (D. Rognan).Subject Index.show more

Author information

Didier Rognan leads the Drug Bioinformatics Group at the Laboratory for Molecular Pharmacochemistry in Illkirch (France). He obtained a graduate degree in Pharmacy from the University of Rennes and completed his PhD in Medicinal Chemistry at the University of Strasbourg under the supervision of Camille G. Wermuth in 1989. Moving to the Swiss Federal Institute of Technology in Z?he became Assistant Professor at the ETH before being named a research director at the CRNS in Illkirch near Strasbourg in 2000. Professor Rognan is mainly interested in all aspects (method development, applications) of protein-based drug design and virtual screening.show more

Review quote

"Die vielfach farbigen Abbildungen und Ubersichten sind von hoher Qualitat. Die Literatur wie gewohnt aktuell und umfangreich." Umwelt & Gesundheitshow more